We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CARDIOME/ASTELLAS: FDA SETBACK FOR HEART DRUG
CARDIOME/ASTELLAS: FDA SETBACK FOR HEART DRUG
June 2, 2006
The FDA has refused to accept an application for a proposed treatment of atrial fibrillation. The approval of Cardiome's new treatment for atrial fibrillation is set to be delayed by almost a year after the FDA refused to file an application for the drug. Pharmaceutical Business Review
